临床外科杂志 ›› 2026, Vol. 34 ›› Issue (5): 518-522.doi: 10.3969/j.issn.1005-6483.20250460

• 论著 • 上一篇    下一篇

血清C-X-C趋化因子受体7和溶质载体家族7成员11与胃癌临床病理特征及病人预后的关系

  

  1. 024000  内蒙古赤峰,赤峰学院附属医院普外科
  • 收稿日期:2025-05-06 接受日期:2025-05-06 出版日期:2026-05-20 发布日期:2026-05-20
  • 通讯作者: 024000 内蒙古赤峰,赤峰学院附属医院普外科
  • 基金资助:
    2022年度自治区高等学校科学研究项目(NJZZ22141)

The Relationship Between Serum C-X-C chemokine receptor 7 and solute carrier family 7 member 11 with cancer pathological features and patient prognosis in gastric cancer

  1. Department of General Surgery,Affiliated Hospital of Chifeng University,Chifeng,Inner Mongolia 024000,China
  • Received:2025-05-06 Accepted:2025-05-06 Online:2026-05-20 Published:2026-05-20

摘要: 目的 探讨血清CXC趋化因子受体7(CXCR7)和溶质载体家族7成员11(SLC7A11)的表达水平与胃癌临床病理特征及病人预后的关系。方法 2021年1月~2024年1月收治的108例胃癌病人为试验组,同期入院体检的50例健康者为对照组。根据预后情况将108例病人分为预后良好组(48例)和预后不良组(60例)。采用qPCR检测血清CXCR7和SLC7A11的mRNA表达水平。分析CXCR7和SLC7A11与胃癌临床病理特征之间的关系,采用Cox回归分析胃癌病人不良预后的风险因素。CXCR7、SLC7A11及联合检测对胃癌病人预后的诊断价值以ROC曲线表示。结果 试验组CXCR7 mRNA、SLC7A11 mRNA分别为1.80±0.56、1.71±0.48,高于对照组的1.03±0.28和0.98±0.27,两组比较差异有统计学意义(P<0.05);预后不良组CXCR7 mRNA、SLC7A11 mRNA分别为2.01±0.59和1.91±0.52,高于预后良好组的1.53±0.32和1.45±0.32,两组比较差异有统计学意义(P<0.05);胃癌病人CXCR7、SLC7A11高表达中,肿瘤直径≥5cm、低分化、TNM分期Ⅲ期、淋巴结转移的病人更多,差异有统计学意义(P<0.05)。Cox分析表明,分化程度、TNM分期、淋巴结转移、CXCR7、SLC7A11水平为胃癌不良预后的危险因素(P<0.05);CXCR7、SLC7A11联合诊断胃癌病人出现预后不良的AUC为0.925(Z联合CXCR7=2.446、Z联合SLC7A11=2.835,P<0.05)。结论 血清CXCR7和SLC7A11高表达与胃癌病人不良预后相关,联合检测对判断病人预后有重要意义。

关键词: C-X-C趋化因子受体7, 溶质载体家族7成员11, 胃癌, 临床病理特征, 预后

Abstract: Objective To investigate the relationship between serum C-X-C chemokine receptor 7 (C-X-CR7) and solute carrier family 7 member 11 (SLC7A11) with clinical pathological features and prognosis of gastric cancer.Methods From January 2021 to January 2024,108 gastric cancer patients diagnosed and treated in our hospital were considered as experimental group,while 50 healthy individuals admitted for physical examine were considered as control group.According to the prognosis,they were grouped into good prognosis group (n=48) and poor prognosis group (n=60).Detection of mRNA expression levels of serum CXCR7 and SLC7A11 by qPCR,The relationship between CXCR7 and SLC7A11 with the clinical pathological features of gastric cancer was discussed,and Cox regression was used to analyze the risk factors for poor prognosis in gastric cancer.The diagnostic value of CXCR7,SLC7A11,and their combination for the prognosis of gastric cancer patients was represented by the ROC curve.Results The CXCR7 mRNA and SLC7A11 mRNA in the experimental group were 1.80±0.56 and 1.71±0.48 respectively,which were higher than those in the control group (1.03±0.28 and 0.98±0.27).There was a statistically significant difference between the two groups (P<0.05).The CXCR7 mRNA and SLC7A11 mRNA in the poor prognosis group were 2.01±0.59 and 1.91±0.52 respectively,which were higher than those in the good prognosis group (1.53±0.32 and 1.45±0.32).There was a statistically significant difference between the two groups (P<0.05).In gastric cancer patients with high CXCR7 and SLC7A11,there were more patients with tumor diameter ≥ 5 cm,low differentiation degree,TNM stage (Ⅲ stage),and lymph node metastasis (P<0.05).Cox analysis showed that differentiation degree,TNM staging,lymph node metastasis,CXCR7,and SLC7A11 were risk factors for poor prognosis of gastric cancer (P<0.05).The AUC of combination of CXCR7 and SLC7A11 in diagnosing poor prognosis in gastric cancer was 0.925 (Z combination CXCR7=2.446,Z combination-SLC7A11=2.835,P<0.05).Conclusion High expression of serum CXCR7 and SLC7A11 is associated with poor prognosis of gastric cancer patients,and the combined test is important for diagnosing the prognosis of patients.

Key words: C-X-C chemokine receptor 7, solute carrier family 7 member 11, gastric cancer, clinical pathological features, prognosis

[1] 张志波. 胆道闭锁术后胆汁湖的处理[J]. 临床外科杂志, 2026, 34(5): 486-489.
[2] 刘梓涛 陈梦荷 彭湃 沈浩元 胡超华. 趋化因子受体4及基质细胞衍生因子1在三阴性乳腺癌组织中的表达及意义[J]. 临床外科杂志, 2026, 34(5): 506-511.
[3] 刘阳 李斌 尹天圣 张雅军. 手术标本磷脂酶Cε1 mRNA、Src同源结构域3蛋白1 mRNA、细胞周期蛋白依赖性激酶12 mRNA联合预测胃癌内镜黏膜下剥离术后早期病情进展的增益价值[J]. 临床外科杂志, 2026, 34(5): 513-517.
[4] 于敏 秦研然. 胃底体积大小、营养状况及幽门梗阻对胃癌根治术后并发胃瘫综合征风险的预测价值[J]. 临床外科杂志, 2026, 34(5): 523-528.
[5] 张鹏 张强 李晓利 刘云. 胰腺癌病人血清微小RNA-451、微小RNA-15a、微小RNA-133b表达及其临床意义[J]. 临床外科杂志, 2026, 34(5): 534-538.
[6] 张帅 廖德祥 程盛 马丹丹 傅涛. 腹部手术后手术部位感染的相关危险因素分析[J]. 临床外科杂志, 2026, 34(5): 544-549.
[7] 侯文 于洪霞 潘雨婷 段佳丽 云红. 年轻结直肠癌腹膜转移病人行细胞减灭术联合腹腔热灌注化疗的有效性分析[J]. 临床外科杂志, 2026, 34(5): 550-555.
[8] 徐跻京 李家轩 曹荣华 黄永高. 肺腺癌气腔播散对肺叶切除术与亚肺叶切除术选择及术后生存转归的影响[J]. 临床外科杂志, 2026, 34(4): 407-411.
[9] 赵庆楠 何代玉 孙笑尘 金丽军. 甲状腺激素应答蛋白Spot 14、尿激酶型纤溶酶原激活物、E26转录因子变异体4与甲状腺乳头状癌颈部淋巴结转移的相关性及预后评估价值[J]. 临床外科杂志, 2026, 34(3): 272-276.
[10] 夏海水 房晓芳 王伟 马上. 血清单酰基甘油酯酶、甘油三磷酸脱氢酶1和人循环前胃泌素表达水平与乳腺癌病人分子分型及预后的关系[J]. 临床外科杂志, 2026, 34(3): 281-285.
[11] 王海 徐幸幸 段文涛 彭勇. 术前血淋巴细胞计数与C反应蛋白的比值、叉头盒蛋白A1对原发性肝癌肝动脉化疗栓塞术术后预后的预测价值分析[J]. 临床外科杂志, 2026, 34(3): 290-295.
[12] 吴梓政 魏元君 郑杰 韩猛. 趋化因子配体9 mRNA在三阴性乳腺癌中的表达及临床意义[J]. 临床外科杂志, 2026, 34(2): 150-155.
[13] 柯贤鹏 王立松 王鹏斌 王琦 陈星晨. 改良股骨髓内钉与动力髋螺钉治疗股骨转子间骨折的临床疗效观察[J]. 临床外科杂志, 2026, 34(2): 205-208.
[14] 陈亦煊, 覃吉超. 美国国家综合癌症网络临床实践指南:胃癌(2025.V3)更新解读[J]. 临床外科杂志, 2026, 34(1): 1-5.
[15] 王坦, 戴旭东, 韩峰, 陈亚东, 霍占伟, 丁永斌. lncRNA TONSL-AS1通过与蛋白质YTHDF2相互作用和竞争性结合微小RNA-144调控胃癌发生机制研究[J]. 临床外科杂志, 2026, 34(1): 63-68.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[2] 赵晋波;李小飞. 侵犯周围器官T4非小细胞肺癌的手术治疗策略[J]. 临床外科杂志, 2017, 25(7): 485 .
[3] 彭银杰 李印 陈威鹏 凃成志 袁俊 马海波 秦建军. 老年cT1N0M0食管癌病人内镜和手术治疗预后分析:基于SEER数据库[J]. 临床外科杂志, 2018, 26(9): 651 -656 .
[4] 林佩达 黄家麒 卢化祥 黄晟 刘光 杨广林 王福音 何冰冰 刘晓兵. 经皮机械性血栓清除术治疗创伤病人下肢深静脉血栓形成的安全性和早期疗效分析[J]. 临床外科杂志, 2018, 26(11): 810 -813 .
[5] 马人杰 贺琦 张海伟 张俊华 郑荣. 腹腔镜完全腹膜外补片植入术治疗腹股沟疝的近期疗效及安全性观察[J]. 临床外科杂志, 2018, 26(11): 862 -864 .
[6] 王硕 王欣然. 重点环节干预在提高重症胰腺炎病人三腔喂养管置入成功率中的应用研究[J]. 临床外科杂志, 2018, 26(11): 877 -879 .
[7] 秦新裕, 许剑民, 任黎, 常文举. 2018版《中国结直肠癌肝转移诊断和综合治疗指南》解读[J]. 临床外科杂志, 2019, 27(1): 9 -13 .
[8] 胡俊杰, 熊治国. 中国胃肠肿瘤外科术后并发症诊断登记规范专家共识(2018版)解读[J]. 临床外科杂志, 2019, 27(1): 39 -41 .
[9] 郭乃铭, 罗筱玮, 彭俊, 徐海涛, 黄梦全, 李裕标. 分体式髌骨爪联合空心螺钉内固定治疗髌骨粉碎性骨折的疗效观察[J]. 临床外科杂志, 2019, 27(2): 158 -159 .
[10] 唐云德, 徐卫国, 于风珍, 尚林强. 椎间孔镜微创技术治疗老年腰椎间盘突出症的临床分析[J]. 临床外科杂志, 2019, 27(5): 439 -442 .